GlobeNewsWire
21 Jul 2026, 11:40 UTC · 9w ago
Verdict
Headline leans bearish. We score OTF −1.00 across two claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
2 claims · scored −1 bearish … +1 bullish
Ademi LLP is investigating Blue Owl (NYSE: OTF) for possible securities fraud related to the collection of excessive fees via artificially inflated asset values.
More negative than 95% of claims this week
Ademi LLP has launched investigations into possible securities fraud or fiduciary breaches regarding GPGI (NYSE: GPGI) and NextCure (NASDAQ: NXTC).
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 77% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is under investigation for possible securities fraud and collecting excessive fees.
More negative than 95% of ticker scores this week
The company is under investigation for possible securities fraud.
More negative than 95% of ticker scores this week
The company is being investigated for possible breaches of fiduciary duty and other law violations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
4h ago
+1.6%
Price is moving against the score
$10.31 vs $10.15 close before publication (Jul 20) · not market-adjusted
OTF chart →
